Malignant tumors induce angiogenesis to be supplied with nutrition and oxygen for the growth of themselves both in primary and metastatic stages. 1) A drug inhibiting tumor angiogenesis will be useful for cancer chemotherapy because it is expected to have lower toxicity than the other drugs which kill cancer cells directly. Many angiogenesis inhibitors such as fumagillin derivative TNP-470, 2) SU-5416, 3) angiostatin 4) and endostatin 5) have been reported to exhibit antitumor or antimetastatic activities. Nucleoside compounds, however, have not been reported yet to have anti-angiogenic activity except for 6-methylmercaptopurine riboside (6-MMPR). 6) Thus, we screened a compound which selectively suppresses the growth of vascular endothelial cells from our nucleoside compound library. As a result, we identified 9-(4-thio-b-Dribo-pentofuranosyl)guanine (4Ј-thioguanosine, 7) as a potent inhibitor. We also describe the in vitro inhibitory effects of derivatives of 4Ј-thioguanosine and the evaluation of in vivo activity of 4Ј-thioguanosine.
MATERIALS AND METHODSCell Lines, Chemicals and Animals Human umbilical vein endothelial cell (HUVEC) and EBM medium were purchased from Clonetics (Walkersville, MD, U.S.A.). Human lung carcinoma PC-9 was originally established by Professor Y. Hayata (Tokyo Medical College, Tokyo, Japan). Human basic fibroblast growth factor (bFGF) and vascular endothelium growth factor (VEGF) were purchased from Progen Biotechnik GmbH (Heidelberg, Deutschland) and PeproTech EC Ltd. (London, U.K.), respectively. Fumagillin and 3-(3,4-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were purchased from Sigma-Aldrich (St. Louis, MO, U.S.A.). Severe combined immunodeficient (SCID) mice were purchased from CLEA Japan, Inc. (Tokyo, Japan).Syntheses of the Derivatives 4Ј-Thionucleosides used in this study were synthesized by the methods which reported the syntheses of 4Ј-thioadenosine 7) and 4Ј-thioguanosine 8) with our modification. Briefly, 1,2,3,5-tetraacetyl-4-thioribofuranose (1) was treated with silylated 6-chloropurine or 2-amino-6-chloropurine in the presence of trimethylsilyl triflate (TMSOTf) in 1,2-dichloroethane at 100°C to afford 4Ј-thionucleosides (2, 3) in ca. 50% yields as anomeric mixtures (b/aϭ 6.5, 3.1, respectively). 2-Amino-6-chloropurine nucleoside (a,b-4) was obtained by the deprotection of 2 in 79% yield. The a-isomer (a-4) could be removed by recrystallization from MeOH to give a pure b-4. 2,6-Diaminopurine nucleoside (a,b-5) was also synthesized from 2 by treatment with aqueous ammonia-MeOH at 80°C in a sealed tube. The a,b-anomers could be separated by reverse phase ODS-column chromatography to afford b-5 in 46% yield. 4Ј-Thioadenosine (6) was synthesized from a,b-3 by the similar method to the preparation of diaminopurine derivative (5). 4Ј-Thioguanosine (7) -5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan. Received October 28, 2003; accepted December 22, 2003 Background: To find a nucleoside with anti-angiogenic activity, we tried to screen an active com...